🔴 HCW Biologics is trading 6.8% down today as XBI declines 2.11%

HCW Biologics is trading 6.8% down now at $2.05 amid broad biotech weakness and a wider risk-off market.

• The XBI sector ETF declines 2.11%, while higher Treasury yields, elevated oil prices, and Federal Reserve uncertainty weigh on risk-sensitive stocks.
• No new company-specific announcement was identified on September 15; the latest filing concerned an amended preliminary proxy statement dated September 9.